Dialysis Providers Respond to HHS’ Kidney Care National Plan
HHS plan details several potential ways to create a more competitive dialysis market
HHS plan details several potential ways to create a more competitive dialysis market
CMS has introduced uncertainty about whether Medicare will participate in that modernization or preserve the old system under a different name. The consequences extend far beyond billing The post In a Maternity Care Crisis, CMS Undermines Efforts To Modernize Care appeared first on MedCity News.
[Sponsored] For US biotech companies developing rare disease therapies, decisions about clinical evidence, patient populations and regulatory advice can have consequences in Europe long before a marketing application is submitted. The post FDA Alignment Is a Starting Point, Not a Rare Disease Strategy for the European Market appeared first on MedCity News.
Dianne Williams said she lost weight and lowered her blood pressure thanks to quarterly doctor appointments, monthly phone calls with a nurse, and a blood pressure cuff she uses at home that transmits data to her care team. “It’s good to have somebody talk to you and tell you what your progress is like. And…
Bill McAdams, a 45-year-old travel nurse from Holiday, Florida, was uninsured last year when he experienced a stroke. He hadn’t been able to afford his agency’s health plan, which would have cost $3,600 monthly to cover him and his wife. The hospital that treated him sent him a bill for $93,000. Janet Marx, 56, of…
By KIM BELLARD I recently read both Plastic, Inc. (Beth Gardiner) and These Are the Plunderers (Gretchen Morgenson and Joshua Rosner), and, boy, am I mad. Nothing in either book really came as a surprise, but the degree to which some people are willing to be greedy at the expense of others is still daunting….
CareValidate expanded its HRT offering for telehealth companies, combining hormone therapy with provider access, pharmacy services and AI-powered care coordination. The post CareValidate Launches Expanded HRT Offering appeared first on MedCity News.
Lycia Therapeutics’ protein-degrading drugs are based on the research of Carolyn Bertozzi, a Stanford chemistry professor and Nobel laureate. Lycia’s lead drug candidate is in development for food allergy, where it could compete against the blockbuster Roche drug Xolair. The post Lycia Lands a $317M IPO for Inflammation Drugs Based on Nobel Prize-Winning Science appeared…
The MATCH IT Act aims to reduce patient matching errors. But a model used by vital records systems could provide a better solution. The post Congress’s Patient Matching Fix Won’t Work — Here’s What Would appeared first on MedCity News.
In most organizations the default access model was built for patient care, not for protecting colleagues. A nurse on another unit, a resident who rotated with them, a department administrator: any of them may technically be able to open the record, even when policy says they should not. The post Physician Mental Health and Health…